Gilead Sciences names Kevin Young COO

Gilead Sciences Inc. said late Tuesday that it was appointing Kevin Young as chief operating officer. Young served for 10 years as Gilead’s vice president of commerical operations and most recently has been a senior advisor to the biotech company. Gilead shares rose 0.2% to $86.35 after hours.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Leave a Reply